# US 2026/0151244 A1 · Acute and chronic devices for modifying flow in body lumens and methods of use thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0151244 A1
- Document ID: US20260151244A1
- Status: Published application
- Kind: A1
- Application number: 19/459,800
- Filed: 2026-01-26
- Published: 2026-06-04
- Earliest claimed: 2020-05-28
- Assignees: Nephronyx Ltd.
- Applicants: Nephronyx Ltd.
- Inventors: Menashe YACOBY; Oren ROTMAN; Sagy KARAVANY; Tanhum FELD; Eyal TEICHMAN
- Web page: https://patentgrep.com/patent/US20260151244A1

## CPC

- A61F 2/966: with relative longitudinal movement between outer sleeve and prosthesis, e.g. using a push rod
- A61F 2/07: Stent-grafts
- A61F 2/92: Stents in the form of a rolled-up sheet expanding after insertion into the vessel {, e.g. with a spiral shape in cross-section}
- A61F 2002/068: {Modifying the blood flow model, e.g. by diffuser or deflector}
- A61F 2002/9505: {having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument}
- A61F 2002/9528: {for retrieval of stents}
- A61F 2250/0039: differing in diameter
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

The acute and chronic devices and methods described herein include a body lumen fluid flow modulator including an upstream flow accelerator and a downstream flow decelerator. The fluid flow modulator preferably includes one or more openings that define a gap/entrainment region that provides a pathway through which additional fluid from a branch lumen(s) is entrained into the fluid stream flowing from the upstream flow accelerator to the downstream flow decelerator. Delivery devices including a sheath and inner assembly also are provided for delivering the flow modulator to the body lumen. The delivery device may maintain the flow modulator in its collapsed, delivery state upon retraction of the sheath for ease of readjustment within the body lumen prior to full deployment of the flow modulator within the body lumen.

## Claims

### Claim 1

A flow modulator device for altering fluid flow through an inferior vena cava of a subject in heart failure, the flow modulator device comprising:
a stent configured to transition between a collapsed delivery state and an expanded deployed state, the stent comprising a fixation area configured to contact an inner wall of the inferior vena cava in the expanded deployed state to maintain the flow modulator device at a target position within the inferior vena cava adjacent to a branch off to a renal vein;
a flow restrictor coupled to the stent, the flow restrictor configured to be selectively actuated to transition between a first position relative to the stent defining a first flow area of the flow modulator device and a second position relative to the stent defining a second flow area of the flow modulator device to modulate flow characteristics within the inferior vena cava, the second flow area less than the first flow area; and
a catheter extending from the flow restrictor and comprising at least one pressure sensor configured to measure pressure associated with the inferior vena cava, the catheter configured to be actuated to transition the flow restrictor between the first and second positions relative to the stent based on the pressure measured via the at least one pressure sensor.

### Claim 2 (depends on 1)

The flow modulator device of claim 1, wherein the stent comprises a frame that is at least partially coated with a biocompatible material.

### Claim 3 (depends on 2)

The flow modulator device of claim 2, wherein the stent comprises a single frame.

### Claim 4 (depends on 1)

The flow modulator device of claim 1, wherein the fixation area of the stent is defined by a largest diameter portion of the stent.

### Claim 5 (depends on 1)

The flow modulator device of claim 1, wherein at least a portion of the stent comprises a constant diameter.

### Claim 6 (depends on 1)

The flow modulator device of claim 1, wherein the stent is configured to maintain its cross-sectional area as the flow restrictor transitions between the first and second positions relative to the stent.

### Claim 7 (depends on 1)

The flow modulator device of claim 1, wherein the stent is configured to self-expand from the collapsed delivery state to the expanded deployed state upon deployment from a delivery device.

### Claim 8 (depends on 1)

The flow modulator device of claim 1, wherein the stent is configured to remain coupled to a delivery device comprising the catheter, and the flow restrictor is configured to remain coupled to the catheter of the delivery device for an acute treatment.

### Claim 9 (depends on 1)

The flow modulator device of claim 1, wherein the stent comprises an upstream component having an inlet, an outlet, and a cross-sectional area that converges from the inlet towards the outlet, a downstream component having an entry, an exit, and a cross-sectional area that diverges from the entry towards the exit.

### Claim 10 (depends on 9)

The flow modulator device of claim 9, wherein the stent comprises an entrainment region between the inlet of the upstream component and the exit of the downstream component, the entrainment region comprising one or more openings, and
wherein the flow modulator device is configured to accelerate a fluid stream passing through the upstream component towards the downstream component and around the flow restrictor to generate a low pressure region in the vicinity of the entrainment region that entrains additional fluid from the renal vein into the fluid stream via the one or more openings as the fluid stream passes into the downstream component.

### Claim 11 (depends on 1)

The flow modulator device of claim 1, wherein the flow restrictor is symmetric about a longitudinal plane extending along a longitudinal axis of the flow modulator device.

### Claim 12 (depends on 1)

The flow modulator device of claim 1, wherein the flow restrictor is configured to be suspended within at least a portion of the stent.

### Claim 13 (depends on 12)

The flow modulator device of claim 12, wherein the position of the flow restrictor relative to the stent defines a cross-sectional area of a circumferential opening formed between the stent and the flow restrictor, and
wherein the flow modulator device is configured to accelerate a fluid stream passing through the stent and around the flow restrictor through the circumferential opening.

### Claim 14 (depends on 1)

The flow modulator device of claim 1, wherein the flow restrictor is compliant.

### Claim 15 (depends on 14)

The flow modulator device of claim 14, wherein a cross-sectional area of at least an upstream portion of the flow restrictor is configured to be selectively adjusted to transition the flow restrictor between the first and second positions relative to the stent.

### Claim 16 (depends on 14)

The flow modulator device of claim 14, wherein the flow restrictor comprises an expandable member configured to be selectively expanded from the first position relative to the stent to the second position relative to the stent to modulate the flow characteristics within the inferior vena cava.

### Claim 17 (depends on 16)

The flow modulator device of claim 16, wherein the expandable member comprises a balloon configured to be selectively inflated and deflated between the first and second positions relative to the stent to modulate the flow characteristics within the inferior vena cava.

### Claim 18 (depends on 1)

The flow modulator device of claim 1, wherein the flow restrictor comprises an upstream region and a downstream region, the upstream region comprising a first end and a cross-sectional area that increases from the first end towards the downstream region, the downstream region comprising a second end and a cross-sectional area that decreases from the upstream region towards the second end.

### Claim 19 (depends on 1)

The flow modulator device of claim 1, wherein the at least one sensor comprises a first pressure sensor disposed on the catheter upstream of the flow restrictor, and a second pressure sensor disposed on the catheter downstream of the flow restrictor, the first and second pressure sensors configured to provide information indicative of a pressure differential across the flow modulator device.

### Claim 20 (depends on 1)

The flow modulator device of claim 1, wherein the at least one sensor comprises a single differential pressure transducer configured to provide information indicative of a pressure differential across the flow modulator device.

### Claim 21 (depends on 1)

The flow modulator device of claim 1, wherein the at least one sensor comprises at least one of an optical pressure sensor or a local diaphragm-based sensor.

### Claim 22 (depends on 1)

The flow modulator device of claim 1, wherein the catheter is configured to be actuated to move the flow restrictor axially between the first and second positions relative to the stent to modulate the flow characteristics within the inferior vena cava.

### Claim 23 (depends on 1)

The flow modulator device of claim 1, wherein the flow modulator device is configured to be disposed within the inferior vena cava such that an inlet of the flow modulator device is positioned upstream of the branch off to the renal vein, and
wherein the flow modulator device is configured to selectively modify the fluid stream passing through the flow modulator device to reduce pressure associated with the inferior vena cava to thereby draw blood from a kidney to the renal vein and then to the inferior vena cava, thereby improving kidney functionality, reducing necrotic damage to the kidney, and/or treating heart failure.

### Claim 24 (depends on 1)

The flow modulator device of claim 1, wherein the flow modulator device is configured for chronic treatment.

### Claim 25 (depends on 1)

The flow modulator device of claim 1, wherein the flow modulator device is configured to be retrieved from the inferior vena cava after a treatment.

### Claim 26

A method for altering fluid flow through an inferior vena cava of a subject in heart failure, the method comprising:
transitioning a stent from a collapsed delivery state to an expanded deployed state at a target position within the inferior vena cava adjacent to a branch off to a renal vein, such that a fixation area of the stent contacts an inner wall of the inferior vena cava in the expanded deployed state to maintain the flow modulator device at the target position within the inferior vena cava;
measuring pressure associated with the inferior vena cava via at least one pressure sensor disposed on a catheter, the catheter extending from a flow restrictor coupled to the stent; and
selectively actuating the catheter to transition the flow restrictor between a first position relative to the stent defining a first flow area of the flow modulator device and a second position relative to the stent defining a second flow area of the flow modulator device to modulate flow characteristics within the inferior vena cava based on the pressure measured via the at least one pressure sensor,
wherein the second flow area is less than the first flow area.

### Claim 27 (depends on 26)

The method of claim 26, wherein transitioning the flow restrictor between the first and second positions relative to the stent comprises transitioning the flow restrictor between the first and second positions relative to the stent while the stent maintains its cross-sectional area.

### Claim 28 (depends on 26)

The method of claim 26, wherein transitioning the flow restrictor between the first and second positions relative to the stent comprises selectively adjusting a cross-sectional area of at least an upstream portion of the flow restrictor.

### Claim 29 (depends on 26)

The method of claim 26, wherein transitioning the stent from the collapsed delivery state to the expanded deployed state at the target position within the inferior vena cava comprises transitioning the stent from the collapsed delivery state to the expanded deployed state at the target position within the inferior vena cava such that an inlet of the flow modulator device is positioned upstream of the branch off to the renal vein, and
wherein selectively actuating the catheter to transition the flow restrictor between the first and second positions relative to the stent comprises selectively modifying the fluid stream passing through the flow modulator device to reduce pressure associated with the inferior vena cava to thereby draw blood from a kidney to the renal vein and then to the inferior vena cava, thereby improving kidney functionality, reducing necrotic damage to the kidney, and/or treating heart failure.

### Claim 30 (depends on 26)

The method of claim 26, further comprising retrieving the flow modulator device from the inferior vena cava after a treatment.
